← Evidence map

ArticleClinical kidney journal2025

Five years of post-marketing liver safety data from the tolvaptan Risk Evaluation and Mitigation Strategy.

Emanuel Lohrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025

this papercites it

Five years of post-marketing liver safety data from the tolvaptan Risk Evaluation and Mitigation Strategy. | OpenQuestion